Ovarian cancer treatment can involve surgery, chemotherapy, targeted medicines, hormone therapy, immunotherapy, or combinations of these approaches. The choice depends on the cancer type, stage, tumor characteristics, overall health, and previous treatment. This informational guide explains common treatment options and medications used in ovarian cancer care, along with factors that may influence treatment planning. Understanding these approaches can help patients and families prepare useful questions for their healthcare team and better understand how treatment decisions are made.
Ovarian cancer treatment is based on several factors, including the type and stage of cancer, whether it has spread, tumor characteristics, overall health, and previous treatments. Many people receive a combination of treatments rather than one approach alone. Surgery and chemotherapy are commonly used, while targeted medicines and other therapies may be considered for specific situations.
How Ovarian Cancer Treatment Is Planned
Doctors first determine the cancer type and stage and evaluate how much disease is present. These findings help the healthcare team decide whether surgery, medication, or a combination is appropriate. Biomarker or genetic testing may also provide information that helps identify treatment options for some patients.
Common considerations include:
- Cancer type and stage
- Tumor grade and characteristics
- Whether the cancer has spread
- Previous treatments and response
- Overall health and other medical conditions
- Genetic or biomarker test results
- Individual treatment goals
For some people, fertility preservation may also be an important consideration when the cancer is diagnosed at an early stage.
What Are the Main Ovarian Cancer Treatment Options
Surgery is an important part of treatment for many ovarian cancers. It may be used to determine the cancer stage and remove as much visible cancer as possible. The extent of surgery depends on the cancer type, how far it has spread, and individual circumstances.
Chemotherapy is another major treatment approach. It may be used after surgery, before surgery to shrink tumors, or for cancer that has spread or returned. A commonly used combination for epithelial ovarian cancer includes a platinum medicine such as carboplatin or cisplatin together with a taxane such as paclitaxel or docetaxel.
Other treatment approaches can include:
- Targeted therapy for cancers with specific characteristics
- Hormone therapy for certain ovarian cancer types
- Immunotherapy in selected situations
- Radiation therapy in specific circumstances
- Clinical trials investigating newer treatment approaches
Ovarian Cancer Treatment Insights
| Treatment approach | How it may be used | Key consideration |
|---|---|---|
| Surgery | Staging and removing visible cancer | Extent depends on cancer spread |
| Chemotherapy | Before or after surgery and for advanced disease | Drug combinations vary |
| Targeted therapy | For certain tumor characteristics | Biomarker testing may help |
| Hormone therapy | Certain ovarian cancer subtypes | Depends on hormone sensitivity |
| Immunotherapy | Selected cancers and clinical settings | Eligibility varies |
| Clinical trials | Investigating newer approaches | Availability depends on location and eligibility |
How Ovarian Cancer Medications Work
Ovarian cancer medications work in different ways. Chemotherapy generally affects rapidly dividing cells, while targeted medicines are designed to interfere with specific proteins, pathways, or changes involved in cancer growth.
Examples of medicines used in ovarian cancer care include:
- Carboplatin: A platinum chemotherapy medicine frequently used in combination treatment.
- Cisplatin: Another platinum medicine that may be used in selected treatment plans.
- Paclitaxel: A taxane chemotherapy medicine commonly combined with carboplatin.
- Bevacizumab: A targeted medicine that may be combined with chemotherapy or used in other treatment settings.
- Olaparib: A PARP inhibitor used for certain ovarian cancers.
- Niraparib: Another PARP inhibitor used in selected patients.
- Rucaparib: A PARP inhibitor that may be considered for particular treatment situations.
PARP inhibitors work by interfering with DNA repair mechanisms. Their usefulness can depend on factors such as BRCA mutations and other tumor characteristics.
The National Cancer Institute maintains a current list of FDA approved medicines for ovarian, fallopian tube, and primary peritoneal cancers.
Why Biomarker Testing Can Matter
Biomarker testing can help doctors understand specific characteristics of a tumor. Some ovarian cancers have genetic or molecular changes that may make particular targeted medicines more appropriate.
Testing may examine factors such as:
- BRCA1 or BRCA2 changes
- Other DNA repair characteristics
- Specific tumor proteins
- Molecular alterations that may qualify for targeted treatment
- Features relevant to clinical trial eligibility
Targeted treatment is not appropriate for every ovarian cancer. The results of testing need to be interpreted together with the cancer stage, previous treatments, overall health, and other clinical information.
How Treatment May Change Over Time
Treatment is not always the same throughout the course of ovarian cancer. A person may receive surgery followed by chemotherapy, while another person may receive chemotherapy before surgery. If cancer returns, doctors may consider different chemotherapy medicines, targeted therapies, hormone therapy, or clinical trials depending on how long the cancer remained controlled and what treatments were previously used.
Side effects can also influence treatment planning. Common chemotherapy effects can include fatigue, nausea, changes in blood counts, and hair loss, although the effects vary by medication and individual.
Tips for Understanding an Ovarian Cancer Treatment Plan
A healthcare team can explain why a particular treatment is being recommended and what alternatives may exist. Useful questions may include:
- How does the cancer type and stage affect treatment?
- What is the purpose of each treatment?
- Which medicines are being considered and why?
- Are biomarker or genetic tests recommended?
- What side effects should be monitored?
- How will doctors evaluate whether treatment is working?
- Are clinical trials appropriate to consider?
- Could treatment affect fertility or other long term health goals?
Conclusion
Ovarian cancer treatment can involve several approaches, including surgery, chemotherapy, targeted therapy, hormone therapy, immunotherapy, and clinical trials. The most appropriate plan depends on the individual cancer and personal circumstances. Medication choices can also change according to tumor characteristics, previous treatment, and response. This guide is for general educational information only and is not a substitute for diagnosis or treatment advice from a qualified healthcare professional.